In this episode, I’m joined by Kate French to explore the critical process of life science business case development. Whether you’re conceptualizing a new product, enhancing an existing feature, or considering your next acquisition, developing a solid business case is the first essential step.
Kate, with her wealth of experience, shares insights on how to build business cases from the ground up—both organically for product development and inorganically for acquisitions. This episode is packed with practical tips for product managers and marketers working to secure investment and drive growth.
Kate breaks down the fundamentals of life science business case development, explaining its importance in securing internal investment for new products, features, or acquisitions.
She shares her experiences in navigating the delicate balance between innovation and market needs, including how to justify or challenge ideas from R&D. This episode offers practical advice for life sciences professionals on how to effectively present a business case that aligns with user demand and business objectives, making it an invaluable guide for driving product and company growth.
Life Science Business Case Tips Inspired by Our Conversation
Use clinical data, patient outcomes, and epidemiological studies to support the need for your product. For example, if launching a medical device, quantify the number of patients who would benefit from your innovation. Ensure that your business case presents a clear, evidence-backed market opportunity, showing potential cost savings, improved outcomes, or faster diagnoses for healthcare providers.
Also, include a detailed regulatory plan outlining approvals needed from agencies like the FDA (510k, PMA) or CE Mark in Europe. Specify timelines, costs, and potential risks involved in gaining regulatory clearance, as this is a critical factor for investors. For instance, highlight previous successful submissions or any clinical data that may expedite the approval process.
Be sure to frame your product in terms of healthcare economics by demonstrating its value to payers and providers. Use data to show how your product reduces healthcare costs, improves efficiency, or lowers readmission rates. For example, illustrate how a new diagnostic tool might reduce costly complications or how a drug-delivery system could reduce hospital stays, providing concrete financial incentives for adoption.
Conduct a detailed competitive analysis showing how your solution is superior to alternatives. Include benchmarks on efficacy, safety, patient outcomes, or ease of use, supported by data. For instance, demonstrate how your device has faster turnaround times or superior clinical accuracy compared to competitors, and explain how this competitive edge will drive adoption.
Build a detailed go-to-market plan that outlines the steps for market entry and growth, including key partnerships with distributors, healthcare institutions, or key opinion leaders. For life sciences companies, it’s critical to show how you’ll scale—whether through direct sales, licensing agreements, or partnerships with larger medtech or pharmaceutical companies. Be sure to include projected timelines, resource needs, and potential barriers.
Address risks specific to life sciences such as regulatory delays, reimbursement challenges, or market acceptance hurdles. Build contingency plans within the business case, showing potential pivots or mitigation strategies. For example, identify alternative markets or applications for your product if primary regulatory or clinical paths encounter obstacles.
